Hoffmann Eitle Life Science IP Seminar 2026
Join Wolf Greenfield at the Hoffmann Eitle Life Science IP Seminar 2026. This three-day seminar offers advanced insights for participants with prior knowledge of patents and intellectual property in the life sciences and pharmaceutical sectors, providing a high-level forum to discuss recent developments, practical challenges, and strategic considerations across Europe and beyond. Topics in focus will include Unified Patent Court (UPC) case law updates, SPCs and EU pharmaceutical reform, major EPO developments and landmark decisions, patent strategy across Europe, enforcement trends in life sciences and Second Medical Use, and AI, biotech, and global policy shifts.
Event Panels
Life Science IP Seminar 2026: AI in Drug Discovery and Patenting
June 9, 2026
Ed Russavage will join Hoffmann Eitle’s Maximilian Keck to discuss AI in drug discovery and patenting at the 2026 Life Science IP Seminar.
Life Science IP Seminar 2026: Enablement of Product and Process Claims Relating to Biotech Inventions — Recent US Case Law
June 11 - June 9, 2026
Jean Ge will hold a presentation titled “Enablement of Product and Process Claims Relating to Biotech Inventions — Recent US Case Law” at Hoffmann Eitle’s 2026 Life Science IP Seminar.